J Korean Med Assoc.  2005 Apr;48(4):308-313. 10.5124/jkma.2005.48.4.308.

Neurotoxicity of Herbal Medicine

• Choi KG

• KMID: 1905307
• DOI: http://doi.org/10.5124/jkma.2005.48.4.308

Abstract

Herbal medicines have been used for thousands of years, and herb preparations are commercially available for the folk remedies or for the promotion of health. In contrast to chemical drugs, herbs are regarded to be non-toxic and safe, because of their natural origin. But accumulating clinical data claim the toxicity of herbal medicine. They can cause adverse effects through (1) toxicity of the herb itself or bioactivation of its metabolites, (2) interaction with prescribed drugs, and (3) heavy metals contaminated in the herbal products. Recent studies have disclosed various neurologic side effects of herbal medicine, including cerebrovascular accident, convulsion, encephalopathy, hallunication, and psychosis. In addition to, some herbs interact with the neurologic therapeutic drugs, such as anticoagulants and antiepileptic drugs, leading to failure to control the patients' diseases. Also, there is growing evidence that herbal medicine products contain potentially harmful levels of lead, mercury and arsenic, all of which have neurotoxicity. Systematic validation of the potency and toxicity of herbal medicines as well as screening of toxic heavy metal content should be warranted.

Keyword

Herbal medicine; Neurotoxicity; Drug interaction; Hevay metals

MeSH Terms

Anticoagulants
Anticonvulsants
Arsenic
Drug Interactions
Health Promotion
Herbal Medicine*
Mass Screening
Medicine, Traditional
Metals, Heavy
Psychotic Disorders
Seizures
Stroke
Anticoagulants
Anticonvulsants
Arsenic
Metals, Heavy

Reference

1. Deng JF. Clinical and laboratory investigations in herbal poisonings. Toxicology. 2002. 181-2:571–576.

2. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system event associated with dietary supplements containing ephedra alkaloid. N Engl J Med. 2000. 343:1833–1838.

3. Miller LG. Herbal medicinals. Arch Intern Med. 1998. 158:2200–2211.

6. Wang XP, Yang RM. Movement disorders possibly induced by traditional Chinese herb. Eur Neurol. 2003. 50:153–159.

7. Sigel RK. Ginseng abuse syndrome. JAMA. 1979. 241:1614–1615.

9. Balikova M. Collective poisoning with hallucinogenous herbal tea. Forensic Sci Inter. 2002. 128:50–52.

10. Boerth JM, Caley CF. Possible case of mania associated with ma-huang. Pharmacotherapy. 2003. 23:380–383.

11. Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med. 1996. 125:940–941.

12. Parkman CA. Another FDA warning: Kava supplements. Case Manager. 2002. 13:26–28.

13. Shintani S, Murase H, Tsukagoshi H. Glycyrrhizin(licorice)-induced hypokalemic myopathy. Eur Neurol. 1992. 32:44–51.

14. Zhou S, Koh HL, Gao Y, Gong A, Lee EJD. Herbsl bioactivation: The good, the bad and the ugly. Life Sci. 2004. 74:935–968.

15. Fugh-Berman A. Herb-drug interaction. Lancet. 2000. 355:134–138.

16. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health-Syst Pharm. 2000. 57:1221–1230.

17. Deahl M. Betel nut-induced extrapyramidal syndrome: an unusual drug interaction. Mov Disord. 1989. 4:330–333.

18. Lantz MS, Buchalter E, Giambanco V. St. John's wort and antidepressant drug interaction in the elderly. J Geriat Psychiat Neurol. 1999. 12:7–10.

19. Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol. 1997. 37:344–350.

20. Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, et al. Heavy metal content of ayurvedic herbal medicine product. JAMA. 2004. 292:2868–2873.

21. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicine. Trend Pharmacol Sci. 2002. 23:136–139.

22. Koh HL, Woo SO. Chinese propertietary medicines in Singapore. Regulatory control of toxic heavy metals and undeclared drugs. Drug Safe. 2000. 23:351–362.

23. Parry GJ. Aminoff MJ, editor. Neurological complications of toxin exposure in the workplace. Neurology and general medicine. 2001. 3rd ed. New York: Churchill Livingstone;654–657.

24. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med. 1993. 328:246–252.